AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 5 - (NewsRx.com & NewsRx.net) -- Immunization with synthetic P-glycoprotein-derived peptides inhibited multidrug resistance of tumors.
"Overexpression of the membrane glycoprotein (P170) represents the most common multidrug resistance (MDR) mechanism in cancer therapy. Specific auto-antibodies to extracellular loops 1, 2, and 4 of murine P170 were elicited in mice using palmitoylated synthetic peptides reconstituted in liposomes, with or without Lipid A, and resuspended in alum. IgM antibodies were detected 14 days following the first injection and IgG1 became predominant after the third challenge," scientists writing in the European Journal of Cancer report.
"Animals did not show any autoimmune symptoms or induced toxicity up to 18 months after the immunization," said C. Pawlak-Roblin at the UFR Pharmacie and collaborators in France and Switzerland. "Previous immunizations of mice using liposomes with MDR1 peptides increase the efficacy of chemotherapy treatments with doxorubicin and vinblastine against P388 R cells with increase of 77% in the survival half time in the immunized group. Sera from the ...